Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New ...
As of February 10 at 3:27:42 PM EST. Market Open.
As of February 11 at 1:47:43 PM EST. Market Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback